(Q33419062)

English

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma (English)
Christopher J Sweeney

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit